Bristol-Myers Squibb
BMY
#191
Rank
NZ$195.91 B
Marketcap
NZ$95.94
Share price
-1.56%
Change (1 day)
17.42%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.14. In 2025 the company made an earnings per share (EPS) of NZ$5.97 an increase over its 2024 EPS that were of NZ-$7.63.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.102.25%
2025NZ$5.97-178.28%
2024NZ-$7.63-213.92%
2023NZ$6.6930.2%
2022NZ$5.14-6.04%
2021NZ$5.47-179.29%
2020NZ-$6.90-281.37%
2019NZ$3.81-27.21%
2018NZ$5.23
2016NZ$4.61175.26%
2015NZ$1.67-19.83%
2014NZ$2.09-22.44%
2013NZ$2.6934.48%
2012NZ$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.07 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.11 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.55-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.70 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.99 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.42-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.13 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.14-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.99 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK